The Motley Fool

FEBRUARY 7, 2025

Quantum computing investing was all the rage in late 2024 after Alphabet 's Google's Willow Chip took the world by surprise. This chip's breakthrough caused many investors to flock to quantum computing stocks, and many, like IonQ (NYSE: IONQ) , posted unbelievable gains in just one month. Nvidia CEO Jensen Huang threw cold water on this hot movement, recently, stating that "useful" quantum computing could be 15 to 30 years away.

Returns 208

Returns Investors Funds Portfolios 208

Private Equity Insights

FEBRUARY 7, 2025

Goldman Sachs Asset Management (GSAM) is seeking up to $3bn for its newly launched West Street Climate Credit Fund, a strategy aimed at financing companies supporting the global shift toward a low-carbon economy The fund will focus on lending to businesses in sectors such as clean energy and sustainable transportation, with an emphasis on North America and Europe.

Funds 147

Funds Pension Funds Asset Management Finance 147

The Motley Fool

FEBRUARY 7, 2025

Shares of Super Micro Computer (NASDAQ: SMCI) , commonly called Supermicro, surged this week, jumping as much as 29.6%, according to data supplied by S&P Global Market Intelligence. As of 3:07 p.m. ET on Friday, the stock was still up 24.4%. There were a couple of catalysts that boosted investor sentiment for the artificial intelligence (AI) hardware specialist.

Stock Exchanges 204

Stock Exchanges Accounting Returns Investors 204

A Wealth of Common Sense

FEBRUARY 7, 2025

Every year I update long-term return numbers for all of my various spreadsheets for charts, graphs, tables and such.1 From 1928-2024, the S&P 500 was up 9.94% on an annual basis. That’s pretty good. The last couple of years have seen strong returns (+26% and +25%, respectively) so I noticed the long-run number was ticking up. After the bloodbath in 2022, the long-term annual return was 9.6%.

Returns 145

Returns 145

The Motley Fool

FEBRUARY 7, 2025

Even if you only have $1,500 on hand to invest in the cryptocurrency sector, it behooves you to deploy your capital judiciously rather than frivolously. With so many cryptocurrency opportunities abounding right now -- including quite a few opportunities to lose all of your money -- sticking to the highest-quality assets is simply not optional. With that in mind, let's dig into one top crypto coin that's worth considering an investment in, and then take a beat to understand another popular coin t

Financial Institutions 162

Financial Institutions Banks Assets Capital 162

Private Equity Wire

FEBRUARY 7, 2025

Mitsubishi Chemical has agreed to sell its pharmaceutical subsidiary, Mitsubishi Tanabe Pharma, to US private equity firm Bain Capital in a deal valued at JPY510bn ($3.36bn) as part of a broader effort to streamline its portfolio. The sale comes amid a surge in private equity-led buyouts in Japan, as companies divest non-core assets to enhance corporate and shareholder value.

Mergers and Acquisitions 84

Mergers and Acquisitions Private Equity Firms Private Equity Firms Buyout 84

The Motley Fool

FEBRUARY 7, 2025

Neurological therapeutics specialist Neurocrine Biosciences (NASDAQ:NBIX) reported mixed fourth-quarter earnings on Thursday, Feb. 6. Despite a slight miss on revenue expectations, its adjusted earnings per share (EPS) beat estimates significantly. Overall, the quarter showcased strong performance, particularly from the flagship prescription medication Ingrezza, underscoring the effectiveness of its strategic initiatives.

Leveraging 130

Leveraging Accounting Portfolios Returns 130

The Motley Fool

FEBRUARY 7, 2025

Derivatives and securities exchange operator Cboe Global Markets (NYSEMKT:CBOE) reported fourth-quarter and full-year 2024 earnings on Friday, Feb. 7, that fell just short of consensus estimates. Its adjusted EPS of $2.10 came in below analyst expectations of $2.13. Net revenue in Q4 stood at $524.5 million, just shy of the predicted $525 million, and showed a 5.1% increase year over year.

Taxes 130

Taxes Assets Returns Investors 130

AltAssets

FEBRUARY 7, 2025

Bain Capital has signed a definitive agreement to acquire Mitsubishi Tanabe Pharma Corporation in a carve-out transaction from Mitsubishi Chemical Group Corporation. The post Deal Roundup: Bain Capital carves out Mitsubishi Tanabe Pharma at $3.3bn valuation, ACON completes Vitalis exit appeared first on AltAssets Private Equity News.

Capital 80

Capital Buyout Funds Investing 80

The Motley Fool

FEBRUARY 7, 2025

On Jan. 30, Walgreens Boots Alliance , a leading pharmacy chain, announced that it was suspending its dividend program, which had been active for over 90 years. This longtime dividend payer is suffering under the weight of financial troubles and had previously resorted to decreasing its payouts. Walgreens isn't the only dividend-paying pharmacy chain whose financial results haven't been strong recently.

Shareholders 130

Shareholders Returns Investors Companies 130

Private Equity Wire

FEBRUARY 7, 2025

Ares Management has elevated two senior partners, Kipp deVeer and Blair Jacobson, to the newly created roles of Co-Presidents, as the firm aims to nearly double its assets under management over the next four years, according to a report by the Financial Times. The move is part of Chief Executive Michael Arougheti’s strategy to expand the leadership team and position the firm for long-term growth.

Assets 59

Assets Capital Investing 59

The Motley Fool

FEBRUARY 7, 2025

Shares of Palantir (NASDAQ: PLTR) were flying this week. The company's stock gained 39.3% as of 1:50 p.m. ET on Friday, and was up as much as 41% earlier in the week. The leap comes as the S&P 500 (SNPINDEX: ^GSPC) was flat, while the Nasdaq-100 gained 0.4% in the week's trading. The artificial intelligence (AI)-powered intelligence and analytics company reported better-than-expected earnings this week, sending shares higher.

Returns 130

Returns Portfolios Companies Investors 130

AltAssets

FEBRUARY 7, 2025

Chicago-based buyout house Longshore Capital Partners has hit its increased hard cap for the $325m final close of its sophomore fund. The post Longshore Capital clears original Fund II hard cap to reach $325m final close appeared first on AltAssets Private Equity News.

Capital 64

Capital Buyout Funds Investing 64

The Motley Fool

FEBRUARY 7, 2025

Shares of Illumina (NASDAQ: ILMN) were falling on Friday. The company's stock was down by as much as 11.4% early in the session, and was still off by 8.7% as of 2:38 p.m. ET. At that time, the S&P 500 had slid by 0.9% and the Nasdaq Composite was down 1.4%. Illumina, a biotech company that develops and manufactures genetic testing systems, reported disappointing fourth-quarter numbers after the closing bell Thursday.

Accounting 130

Accounting Returns Investors Portfolios 130

FinSMEs

FEBRUARY 7, 2025

Centerseat, an Austin, TX-based physical security compliance company, raised $2.7M in Seed funding. The round was led by Silverton Partners, with participation from angel investors. The company intends to use the funds to expand operations and its development efforts. Founded by Thomas Kopeckyand Mat Thompson, Led by CEO Thomas Kopecky, Centerseat leverages AI-driven insights, situational […] The post Centerseat Raises $2.7M in Seed Funding appeared first on FinSMEs.

Angel Investors 58

Angel Investors Funds Leveraging Investors 58

The Motley Fool

FEBRUARY 7, 2025

Snap (NYSE: SNAP) faced a series of challenges over the last few years. Many of them originated from an adjustment to Apple 's privacy rules in 2021, which made it difficult for app developers to track their users across the internet. It meant Snap could no longer sell highly targeted advertising slots to businesses on its social media platform, Snapchat.

Accounting 221

Accounting Capital Companies Investing 221

FinSMEs

FEBRUARY 7, 2025

Avelios Medical, Munich, Germany-based provider of a hospital information system (HIS), 30M in Series A funding. The round was led by Sequoia Capital alongside existing investors Revent and HTGF. The company intends to use the funds to expand operations and development efforts. Funded in 2020 by Christian Albrecht, Nicolas Jakob, and Dr. Sebastian Krammer, Avelios […] The post Avelios Medical Raises 30M in Series A Funding appeared first on FinSMEs.

Funds 58

Funds Capital Investors Companies 58

The Motley Fool

FEBRUARY 7, 2025

In this video, I will cover the recent updates regarding Grab (NASDAQ: GRAB). Watch the short video to learn more, consider subscribing, and click the special offer link below. *Stock prices used were from the trading day of Feb. 6, 2025. The video was published on Feb. 6, 2025. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now.

Returns 130

Returns Companies Investing 130

Private Equity Wire

FEBRUARY 7, 2025

Northcote Equity (Northcote), a newly established private equity firm, has held the first and final close of its maiden fund, Northcote Fund I, at its hard cap of 160m, only 16 weeks after commencing fundraising. Northcote specialises in technology and services investments in the UK and Ireland. Taking a high-conviction and flexible approach, the team can support both minority and majority structures, investing up to 30m of equity in buyout and growth capital investments.

Private Equity Firms 52

Private Equity Firms Private Equity Firms Buyout Funds 52

The Motley Fool

FEBRUARY 7, 2025

Palantir Technologies (NASDAQ: PLTR) was the best-performing member of the S&P 500 (SNPINDEX: ^GSPC) in 2024, and the company carried that momentum into 2025. Earlier this week, Palantir announced exceptional fourth-quarter financial results driven by strong demand for its artificial intelligence platform. The stock rose more than 20% on the news, pushing Palantir's market value to $230 billion.

Banks 208

Banks Accounting Financing Finance 208

AltAssets

FEBRUARY 7, 2025

Private markets investment major Hamilton Lane has hit a $615m final close for its hybrid Venture Access Fund, which will target both primary and secondary deals in the segment. The post Hamilton Lane beats target for $615m hybrid primary, secondaries VC fund appeared first on AltAssets Private Equity News.

Funds 59

Funds Venture Capital Investing Buyout 59

The Motley Fool

FEBRUARY 7, 2025

Many investors are worried about DeepSeek's latest breakthrough. Its Chinese developers claim to have trained a generative AI model that's on a par with many of the U.S. versions for under $6 million. This has caused many AI-related stocks to sell off, although some have remained strong. One stock that's still well off its all-time highs (although for reasons unassociated with DeepSeek) is SoundHound AI (NASDAQ: SOUN).

Bidding 189

Bidding Prospects Financing Finance 189

AltAssets

FEBRUARY 7, 2025

The volume of the global secondaries market grew more than 44% last year compared to 2023, reaching over $153bn, new research from Setter Capital shows. The post Global secondaries volume rises 44% year-on-year to hit $153bn appeared first on AltAssets Private Equity News.

Capital 59

Capital Buyout Funds Investing 59

The Motley Fool

FEBRUARY 7, 2025

Chinese artificial intelligence (AI) start-up DeepSeek sent shockwaves through the U.S. tech sector after its cost-effective, open-source, large language model (LLM) topped the download charts in Apple 's App Store in the U.S., overtaking OpenAI's ChatGPT, which has been pouring billions of dollars in its AI infrastructure and burning through cash. The Chinese company claims that it trained its DeepSeek-V3 model, which was launched on Jan. 10, with just $6 million.

Bidding 182

Bidding Education Companies Investors 182

Vistra

FEBRUARY 7, 2025

The BVI Business Companies (Amendment) Act 2024 ("Amendment Act"), published in the BVI Gazette on 26 September 2024, officially came into force on 2 January 2025 (the Effective Date). The Amendment Act introduces several important changes to the BVI Business Companies Act, aimed at enhancing the jurisdiction's capabilities in combating money laundering, with a focus on transparency and international best practices.

Companies 52

Companies Best Practices 52

The Motley Fool

FEBRUARY 7, 2025

The Hershey Company (NYSE: HSY) needs little introduction given its position as one of the largest confectionery companies in the United States. You have probably indulged in one of its products, like a Hershey bar or Reese's, sometime in the recent past. But Hershey is facing one major problem and a couple of smaller ones right now, which could set up a buying opportunity for long-term investors.

Portfolios 147

Portfolios Investors Returns Companies 147

Financial Times M&A

FEBRUARY 7, 2025

French group launches search for new investors, with approaches made to several tech companies including Apple

Stakes 103

Stakes Investors Companies 103

The Motley Fool

FEBRUARY 7, 2025

Did you know that in the past five years, the S&P 500 's total return (which includes dividends) is around 100%? That's even including a disastrous year for the markets in 2022 when many stocks incurred significant declines. The S&P 500's long-run average is approximately 10% but over the past five years, its compound annual growth rate is up around 15%.

Funds 147

Funds Investing Stock Market Stock Market 147

Motley Fool Asset Management

FEBRUARY 7, 2025

If youre like most people, you probably think a lot about when you should be putting money into the market. Everyone knows the adage to "buy low and sell high".

Investing 103

Investing 103

The Motley Fool

FEBRUARY 7, 2025

In today's video, I discuss Advanced Micro Devices (NASDAQ: AMD) and its recently reported earnings. To learn more, check out the short video, consider subscribing, and click the special offer link below. *Stock prices used were the after-market prices of Feb. 4, 2025. The video was published on Feb. 4, 2025. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now.

Returns 147

Returns Companies Investing 147

Financial Times M&A

FEBRUARY 7, 2025

Company looking at potential flotation as soon as next year in what would be a boost for LSE

Companies 95

Companies 95

The Motley Fool

FEBRUARY 7, 2025

It's been a rocky year for Nvidia (NASDAQ: NVDA) investors. After soaring to new heights, the chipmaker was taken out behind the woodshed and soundly thrashed, at one point losing as much as 22% of its value. There was widespread panic among some investors after Chinese artificial intelligence (AI) start-up DeepSeek claimed that its R1 model delivered state-of-the-art results at a fraction of the cost.

Investors 147

Investors Shareholders Returns Capital 147

Financial Times M&A

FEBRUARY 7, 2025

Private equity firm expects $3.

Private Equity Firms 90

Private Equity Firms Private Equity Firms Companies 90

The Motley Fool

FEBRUARY 7, 2025

Tesla 's (NASDAQ: TSLA) sales have dropped dramatically in Europe to start 2025 and that could be a preview of what's to come for a company facing increased competition and falling prices. In this video, Travis Hoium explains why this could all be bad for Tesla's revenue and bottom line this year. *Stock prices used were end-of-day prices of Feb. 4, 2025.

Returns 147

Returns Companies Investing 147

Financial Times: Moral Money

FEBRUARY 7, 2025

Lofty green pledges and targets will count for little without the dynamic economic activity to make them real

85

85

The Motley Fool

FEBRUARY 7, 2025

Alibaba (NYSE: BABA) stock jumped more than 7% in early trading on the NYSE Friday, before turning tail and giving back nearly half its gains. As of 11:05 a.m. ET, shares of the Chinese e-commerce and technology giant are still up 4.1%. The question now is: Does Alibaba stock deserve to stay up even this much? Because today's wild ride in Alibaba stock appears to derive entirely from competing rumors regarding Chinese artificial intelligence wunderkind DeepSeek.

Stock Market 133

Stock Market Stock Market Investors Returns 133

Financial Times M&A

FEBRUARY 7, 2025

Share price rises 20 per cent as the tie-up is announced

56

56